losartan has been researched along with deoxyguanosine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aghaeishahsavari, M; Argani, H; Babaei, H; Ghorbanihaghjo, A; Mesgari, M; Noroozianavval, M; Rashtchizadeh, N; Safa, J; Veisi, P | 1 |
| Gao, P; Lu, X; Shi, XZ; Xu, GW; Yuan, KL | 1 |
| de Faria, JB; de Faria, JM; Rosales, MA; Silva, KC | 1 |
| Fujishima, H; Fujita, H; Komatsu, K; Morii, T; Narita, T; Sakamoto, T; Takahashi, T; Yamada, Y | 1 |
| Ahmed, SB; Beaudin, AE; Foster, GE; Hanly, PJ; Pialoux, V; Poulin, MJ | 1 |
| Bigagli, E; Di Serio, C; Lodovici, M; Raimondi, L; Tarantini, F | 1 |
3 trial(s) available for losartan and deoxyguanosine
| Article | Year |
|---|---|
Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Ataxia Telangiectasia Mutated Proteins; Biomarkers; Cell Cycle Proteins; Deoxyguanosine; DNA Damage; Enalapril; Female; Humans; Kidney Transplantation; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Protein Serine-Threonine Kinases; Renin-Angiotensin System | 2008 |
Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Benzimidazoles; Benzoates; Cross-Over Studies; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Japan; Losartan; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Superoxide Dismutase; Telmisartan; Tyrosine | 2011 |
Losartan abolishes oxidative stress induced by intermittent hypoxia in humans.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin II Type 1 Receptor Blockers; Cross-Over Studies; Deoxyguanosine; Double-Blind Method; Humans; Hypoxia; Losartan; Male; Nitric Oxide; Oxidative Stress; Tyrosine; Uric Acid | 2011 |
3 other study(ies) available for losartan and deoxyguanosine
| Article | Year |
|---|---|
[Assessment of therapeutic effect of losartan on diabetes mellitus with gas chromatography-based metabonomics].
Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Biomarkers; Chromatography, Gas; Creatinine; Deoxyguanosine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Monitoring; Humans; Hypoglycemic Agents; Inositol; Losartan; Metabolome; Sorbitol | 2007 |
Reduction of inducible nitric oxide synthase via angiotensin receptor blocker prevents the oxidative retinal damage in diabetic hypertensive rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Down-Regulation; Losartan; Male; Nitrates; Nitric Oxide Synthase Type II; Nitrites; Osmolar Concentration; Oxidation-Reduction; Rats; Rats, Inbred SHR; Retina; Superoxide Dismutase; Tyrosine; Up-Regulation | 2010 |
Losartan reduces oxidative damage to renal DNA and conserves plasma antioxidant capacity in diabetic rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Deoxyguanosine; Diabetes Mellitus, Experimental; DNA; DNA Damage; Enzyme-Linked Immunosorbent Assay; Hyperglycemia; Kidney; Lipids; Losartan; Malondialdehyde; Oxidative Stress; Oxygen; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species | 2015 |